Reuters logo
BRIEF-Cadila Healthcare says Zydus begins phase II trial of drug for treating anemia in CKD patients
July 5, 2017 / 5:54 AM / 5 months ago

BRIEF-Cadila Healthcare says Zydus begins phase II trial of drug for treating anemia in CKD patients

July 5 (Reuters) - Cadila Healthcare Ltd

* Says Zydus starts phase II trial of Zyan1 for treating anemia in patients with CKD. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below